Remifentanil Completed Phase 4 Trials for Urinary Tract Problem Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01303627Safety of Remifentanil Infusion